| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Experimental Medical Science, Lund University, Lund, Sweden
2 Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois, United States
3 Pediatrics, Children's Hospital Medical Center, Cincinnati, Ohio, United States
4 Obstetrics and Gynecology, Lund University, Lund, Sweden
5 Surgery, Lund University, Lund, Sweden
* To whom correspondence should be addressed. E-mail: maria.gomez{at}med.lu.se.
The calcineurin/NFAT signaling pathway has been found to play a role in regulating growth and differentiation in several cell types. However, the functional significance of NFAT in the vasculature is largely unclear. Here we show that NFATc1, NFATc3 and NFATc4 are expressed in human myometrial arteries. Confocal immunofluorescence and western blot analysis revealed that endothelin-1 efficiently increases NFATc3 nuclear accumulation in native arteries. Endothelin-1 also stimulates NFAT-dependent transcriptional activity, as shown by a luciferase reporter assay. Both the agonist-induced NFAT nuclear accumulation and transcriptional activity were prevented by the calcineurin inhibitor cyclosporin A and by the novel NFAT blocker A-285222. Chronic inhibition of NFAT significantly reduced IL-6 production in intact myometrial arteries and inhibited cell proliferation in vascular smooth muscle cells cultured from explants from the same arteries. Further, using small-interfering-RNA-mediated reduction of NFATc3, we show that this isoform is involved in the regulation of cell proliferation. Protein synthesis in intact arteries was investigated using autoradiography of [35S]methionine incorporation in serum-free culture. Inhibition of NFAT signaling did not affect overall protein synthesis or specifically the synthesis rates of major proteins associated with the contractile/cytoskeletal system. An intact contractile phenotype under these conditions was also shown by unchanged force response to depolarization or agonist stimulation. Our results demonstrate NFAT expression and activation in native human vessels and point out A-285222 as a powerful pharmacological blocker of NFAT signaling in the vasculature.
This article has been cited by other articles:
|
|
 |
|
  A. Courtwright, S. Siamakpour-Reihani, J. L. Arbiser, N. Banet, E. Hilliard, L. Fried, C. Livasy, D. Ketelsen, D. B. Nepal, C. M. Perou, et al. Secreted Frizzle-Related Protein 2 Stimulates Angiogenesis via a Calcineurin/NFAT Signaling Pathway Cancer Res., June 1, 2009; 69(11): 4621 - 4628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Schlondorff, D. del Camino, R. Carrasquillo, V. Lacey, and M. R. Pollak TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription Am J Physiol Cell Physiol, March 1, 2009; 296(3): C558 - C569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Orr, M. Y. Lee, J. A. Lemmon, A. Yurdagul Jr, M. F. Gomez, P. D. Schoppee Bortz, and B. R. Wamhoff Molecular Mechanisms of Collagen Isotype-Specific Modulation of Smooth Muscle Cell Phenotype Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 225 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. de Frutos, L. Duling, D. Alo, T. Berry, O. Jackson-Weaver, M. Walker, N. Kanagy, and L. Gonzalez Bosc NFATc3 is required for intermittent hypoxia-induced hypertension Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2382 - H2390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. de Frutos, R. Spangler, D. Alo, and L. V. G. Bosc NFATc3 Mediates Chronic Hypoxia-induced Pulmonary Arterial Remodeling with {alpha}-Actin Up-regulation J. Biol. Chem., May 18, 2007; 282(20): 15081 - 15089. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
